Linfoma de Hodkin en Chile: Experiencia de 15 años del Programa Nacional de Cáncer del Adulto
Background: Hodgkin lymphoma is a highly curable disease. Aim: To evaluate the clinical characteristics and the treatment results of Hodgkin lymphoma patients of the National Cancer Program in Chile. Patients and methods: Prospective assessment of 682 patients treated in 18 adult cancer centers. Pro...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , , |
|---|---|
| Lenguaje: | Spanish / Castilian |
| Publicado: |
Sociedad Médica de Santiago
2007
|
| Materias: | |
| Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007000300009 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:scielo:S0034-98872007000300009 |
|---|---|
| record_format |
dspace |
| spelling |
oai:scielo:S0034-988720070003000092014-01-06Linfoma de Hodkin en Chile: Experiencia de 15 años del Programa Nacional de Cáncer del AdultoCabrera C,M ElenaGarcía L,HernánLois V,VivianLeón R,AlvaroPeña N,KarinaRossle S,AlbertoCerda A,BertaRojas R,HernánMeneses C,PedroMerino M,CarlosAspillaga M,AugustoVittini de R,CeciliaOliva L,JacquelineHales D,CeciliaRosas H,Janet Antineoplastic protocols chemotherapy, adjunvant Hodgkin disease Radiotherapy Background: Hodgkin lymphoma is a highly curable disease. Aim: To evaluate the clinical characteristics and the treatment results of Hodgkin lymphoma patients of the National Cancer Program in Chile. Patients and methods: Prospective assessment of 682 patients treated in 18 adult cancer centers. Progression free survival (PFS) and overall survival (OS) were calculated. Median follow up was 127, 95, 87, 72 and 50 months for C-MOPP, radiotherapy (RT), C-MOPP/ABV, NOVP and ABVD, respectively. Results: Median age was 37 years (15-84). Nodular sclerosis and mixed cellularity were equally expressed. Advanced stages (III & IV) were present at diagnosis in 61% of cases. Age over 40 was an adverse prognostic factor (p <0.001). The rate of PFS at 5 and 10 years for early stages was 73% and 66% with RT, 80% and 74% with C-MOPP+RT, 73% and 71% with C-MOPP/ABV, 59% and 59% with NOVP+RT, and 81% with ABVD+RT, at 5 years, being significantly lower for NOVP (p =0.02). The rate of OS at 5 and 10 years for advanced stages was 82% and 70% with RT, 82% and 76% with C-MOPP+RT, 82% and 80% with C-MOPP/ABV, 68% and 60% with NOVP, and 85% with ABVD at 5 years, also significantly lower for NOVP (p =0.04). For advanced stages, the rate of PFS at 5 and 10 years was 49% and 43% with C-MOPP, 69% and 62% with C-MOPP/ABVD or C-MOPP/ABV, and 71% at 5 years with ABVD, significantly lower for C-MOPP (p =0.01). The rate of OS at 5 and 10 years was 52% and 46% with C-MOPP, 70% and 63% with C-MOPP/ABVD or C-MOPP/ABV and 76% with ABVD at 5 years, significantly lower for C-MOPP (p =0.0002). Conclusions: Age over 40 years was an adverse prognostic factor. C-MOPP/ABVD, C-MOPP/ABV and ABVD had comparable results and reached a high tumor control and overall survival in both early and advanced stagesinfo:eu-repo/semantics/openAccessSociedad Médica de SantiagoRevista médica de Chile v.135 n.3 20072007-03-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007000300009es10.4067/S0034-98872007000300009 |
| institution |
Scielo Chile |
| collection |
Scielo Chile |
| language |
Spanish / Castilian |
| topic |
Antineoplastic protocols chemotherapy, adjunvant Hodgkin disease Radiotherapy |
| spellingShingle |
Antineoplastic protocols chemotherapy, adjunvant Hodgkin disease Radiotherapy Cabrera C,M Elena García L,Hernán Lois V,Vivian León R,Alvaro Peña N,Karina Rossle S,Alberto Cerda A,Berta Rojas R,Hernán Meneses C,Pedro Merino M,Carlos Aspillaga M,Augusto Vittini de R,Cecilia Oliva L,Jacqueline Hales D,Cecilia Rosas H,Janet Linfoma de Hodkin en Chile: Experiencia de 15 años del Programa Nacional de Cáncer del Adulto |
| description |
Background: Hodgkin lymphoma is a highly curable disease. Aim: To evaluate the clinical characteristics and the treatment results of Hodgkin lymphoma patients of the National Cancer Program in Chile. Patients and methods: Prospective assessment of 682 patients treated in 18 adult cancer centers. Progression free survival (PFS) and overall survival (OS) were calculated. Median follow up was 127, 95, 87, 72 and 50 months for C-MOPP, radiotherapy (RT), C-MOPP/ABV, NOVP and ABVD, respectively. Results: Median age was 37 years (15-84). Nodular sclerosis and mixed cellularity were equally expressed. Advanced stages (III & IV) were present at diagnosis in 61% of cases. Age over 40 was an adverse prognostic factor (p <0.001). The rate of PFS at 5 and 10 years for early stages was 73% and 66% with RT, 80% and 74% with C-MOPP+RT, 73% and 71% with C-MOPP/ABV, 59% and 59% with NOVP+RT, and 81% with ABVD+RT, at 5 years, being significantly lower for NOVP (p =0.02). The rate of OS at 5 and 10 years for advanced stages was 82% and 70% with RT, 82% and 76% with C-MOPP+RT, 82% and 80% with C-MOPP/ABV, 68% and 60% with NOVP, and 85% with ABVD at 5 years, also significantly lower for NOVP (p =0.04). For advanced stages, the rate of PFS at 5 and 10 years was 49% and 43% with C-MOPP, 69% and 62% with C-MOPP/ABVD or C-MOPP/ABV, and 71% at 5 years with ABVD, significantly lower for C-MOPP (p =0.01). The rate of OS at 5 and 10 years was 52% and 46% with C-MOPP, 70% and 63% with C-MOPP/ABVD or C-MOPP/ABV and 76% with ABVD at 5 years, significantly lower for C-MOPP (p =0.0002). Conclusions: Age over 40 years was an adverse prognostic factor. C-MOPP/ABVD, C-MOPP/ABV and ABVD had comparable results and reached a high tumor control and overall survival in both early and advanced stages |
| author |
Cabrera C,M Elena García L,Hernán Lois V,Vivian León R,Alvaro Peña N,Karina Rossle S,Alberto Cerda A,Berta Rojas R,Hernán Meneses C,Pedro Merino M,Carlos Aspillaga M,Augusto Vittini de R,Cecilia Oliva L,Jacqueline Hales D,Cecilia Rosas H,Janet |
| author_facet |
Cabrera C,M Elena García L,Hernán Lois V,Vivian León R,Alvaro Peña N,Karina Rossle S,Alberto Cerda A,Berta Rojas R,Hernán Meneses C,Pedro Merino M,Carlos Aspillaga M,Augusto Vittini de R,Cecilia Oliva L,Jacqueline Hales D,Cecilia Rosas H,Janet |
| author_sort |
Cabrera C,M Elena |
| title |
Linfoma de Hodkin en Chile: Experiencia de 15 años del Programa Nacional de Cáncer del Adulto |
| title_short |
Linfoma de Hodkin en Chile: Experiencia de 15 años del Programa Nacional de Cáncer del Adulto |
| title_full |
Linfoma de Hodkin en Chile: Experiencia de 15 años del Programa Nacional de Cáncer del Adulto |
| title_fullStr |
Linfoma de Hodkin en Chile: Experiencia de 15 años del Programa Nacional de Cáncer del Adulto |
| title_full_unstemmed |
Linfoma de Hodkin en Chile: Experiencia de 15 años del Programa Nacional de Cáncer del Adulto |
| title_sort |
linfoma de hodkin en chile: experiencia de 15 años del programa nacional de cáncer del adulto |
| publisher |
Sociedad Médica de Santiago |
| publishDate |
2007 |
| url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872007000300009 |
| work_keys_str_mv |
AT cabreracmelena linfomadehodkinenchileexperienciade15anosdelprogramanacionaldecancerdeladulto AT garcialhernan linfomadehodkinenchileexperienciade15anosdelprogramanacionaldecancerdeladulto AT loisvvivian linfomadehodkinenchileexperienciade15anosdelprogramanacionaldecancerdeladulto AT leonralvaro linfomadehodkinenchileexperienciade15anosdelprogramanacionaldecancerdeladulto AT penankarina linfomadehodkinenchileexperienciade15anosdelprogramanacionaldecancerdeladulto AT rosslesalberto linfomadehodkinenchileexperienciade15anosdelprogramanacionaldecancerdeladulto AT cerdaaberta linfomadehodkinenchileexperienciade15anosdelprogramanacionaldecancerdeladulto AT rojasrhernan linfomadehodkinenchileexperienciade15anosdelprogramanacionaldecancerdeladulto AT menesescpedro linfomadehodkinenchileexperienciade15anosdelprogramanacionaldecancerdeladulto AT merinomcarlos linfomadehodkinenchileexperienciade15anosdelprogramanacionaldecancerdeladulto AT aspillagamaugusto linfomadehodkinenchileexperienciade15anosdelprogramanacionaldecancerdeladulto AT vittinidercecilia linfomadehodkinenchileexperienciade15anosdelprogramanacionaldecancerdeladulto AT olivaljacqueline linfomadehodkinenchileexperienciade15anosdelprogramanacionaldecancerdeladulto AT halesdcecilia linfomadehodkinenchileexperienciade15anosdelprogramanacionaldecancerdeladulto AT rosashjanet linfomadehodkinenchileexperienciade15anosdelprogramanacionaldecancerdeladulto |
| _version_ |
1718436310772875264 |